Ultraviolet B-induced inflammatory cytokine production, in vivo: initial pharmacological characterization.
Department of Inflammation and Respiratory Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, USA.
D E
DE
Griswold
M N
MN
Tzimas
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D016207:Cytokines / Q000096:biosynthesis*; D004307:Dose-Response Relationship, Radiation; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D009288:Naproxen / Q000494:pharmacology; D009195:Peroxidase / Q000037:antagonists & inhibitors; D011760:Pyrrolidinones / Q000494:pharmacology; D020889:Rolipram; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D014466:Ultraviolet Rays
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016207:Cytokines; D011760:Pyrrolidinones; D014409:Tumor Necrosis Factor-alpha; D009288:Naproxen; D009195:Peroxidase; D020889:Rolipram